These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1965481)
21. [Poisons of DNA topoisomerases I and II]. Charcosset JY; Soues S; Laval F Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034 [TBL] [Abstract][Full Text] [Related]
22. Effect of protein kinase ck2 on topoisomerase I from plasmodia of the slime mold Physarum polycephalum. Derlacz RA; Kowalska-Loth B; Staroń K Acta Biochim Pol; 1998; 45(3):769-73. PubMed ID: 9918503 [TBL] [Abstract][Full Text] [Related]
23. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH; Castora FJ Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321 [TBL] [Abstract][Full Text] [Related]
24. Induction of topoisomerase I-mediated DNA cleavage by a new indolocarbazole, ED-110. Yoshinari T; Yamada A; Uemura D; Nomura K; Arakawa H; Kojiri K; Yoshida E; Suda H; Okura A Cancer Res; 1993 Feb; 53(3):490-4. PubMed ID: 8381047 [TBL] [Abstract][Full Text] [Related]
25. Phosphorylation sites for type N II protein kinase in DNA-topoisomerase I from calf thymus. Coderoni S; Paparelli M; Gianfranceschi GL Int J Biochem; 1990; 22(7):737-46. PubMed ID: 2169438 [TBL] [Abstract][Full Text] [Related]
26. DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin. Bailly C; Riou JF; Colson P; Houssier C; Rodrigues-Pereira E; Prudhomme M Biochemistry; 1997 Apr; 36(13):3917-29. PubMed ID: 9092822 [TBL] [Abstract][Full Text] [Related]
27. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities. Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102 [TBL] [Abstract][Full Text] [Related]
28. Use of immobilized triazine dyes in the purification of DNA topoisomerase I (Topo I) and terminal deoxynucleotidyl transferase (TdT) from calf thymus. Markauskas A; Tiknius V; Marcisauskas R J Chromatogr; 1991 Feb; 539(2):525-9. PubMed ID: 1646212 [TBL] [Abstract][Full Text] [Related]
29. Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II. Adjei AA; Charron M; Rowinsky EK; Svingen PA; Miller J; Reid JM; Sebolt-Leopold J; Ames MM; Kaufmann SH Clin Cancer Res; 1998 Mar; 4(3):683-91. PubMed ID: 9533538 [TBL] [Abstract][Full Text] [Related]
30. In vivo antitumor activity of two new seven-substituted water-soluble camptothecin analogues. Emerson DL; Besterman JM; Brown HR; Evans MG; Leitner PP; Luzzio MJ; Shaffer JE; Sternbach DD; Uehling D; Vuong A Cancer Res; 1995 Feb; 55(3):603-9. PubMed ID: 7834631 [TBL] [Abstract][Full Text] [Related]
31. DNA-binding activity and cytotoxicity of Pt-berenil compounds in MDA-MB-231 and MCF-7 breast cancer cells. Bielawski K; Bielawska A; Słodownik T; Popławska B; Bołkun-Skórnicka U Acta Pol Pharm; 2008; 65(1):135-40. PubMed ID: 18536187 [TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of a novel ATP-independent type I DNA topoisomerase from a marine methylotroph. Kwack MS; Park JE; Park JK; Lee JS Arch Biochem Biophys; 2005 May; 437(2):168-77. PubMed ID: 15850556 [TBL] [Abstract][Full Text] [Related]
33. Isolation of an 11-kDa protein associated with the topoisomerase I activity from equine infectious anemia virus. Matsrafi L; Aflalo E; Blair DG; Priel E Biochem Biophys Res Commun; 1996 Mar; 220(3):1028-35. PubMed ID: 8607786 [TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular interactions between intoplicine, DNA, and topoisomerase II studied by surface-enhanced Raman scattering spectroscopy. Morjani H; Riou JF; Nabiev I; Lavelle F; Manfait M Cancer Res; 1993 Oct; 53(20):4784-90. PubMed ID: 8402662 [TBL] [Abstract][Full Text] [Related]
35. Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Yamashita Y; Fujii N; Murakata C; Ashizawa T; Okabe M; Nakano H Biochemistry; 1992 Dec; 31(48):12069-75. PubMed ID: 1333791 [TBL] [Abstract][Full Text] [Related]
36. Escherichia coli DNA topoisomerase III: purification and characterization of a new type I enzyme. Srivenugopal KS; Lockshon D; Morris DR Biochemistry; 1984 Apr; 23(9):1899-906. PubMed ID: 6326814 [TBL] [Abstract][Full Text] [Related]
37. Specific cleavage of chicken alpha A-globin and human c-Ha-ras genes by two molecular forms of calf thymus topoisomerase I. Bronstein IB; Gromova II; Razin SV Mol Cell Biochem; 1991 Mar; 101(2):115-24. PubMed ID: 1650425 [TBL] [Abstract][Full Text] [Related]
38. Specific regulatory role of phosphorylation of calf thymus DNA-topoisomerase I smaller forms on the relaxational activity expression. Phosphorylation role on Topo I smaller forms activity. Coderoni S; Paparelli M; Gianfranceschi GL Mol Biol Rep; 1992 May; 16(2):75-80. PubMed ID: 1318999 [TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. Schomburg U; Grosse F Eur J Biochem; 1986 Nov; 160(3):451-7. PubMed ID: 3023077 [TBL] [Abstract][Full Text] [Related]
40. Optimum DNA relaxation reaction conditions for calf thymus DNA-topoisomerase I are determined by specific enzyme features. Coderoni S; Paparelli M; Gianfranceschi GL Mol Biol Rep; 1990 Nov; 14(4):255-9. PubMed ID: 1965603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]